219 RBH, LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Apr 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 27, 2027The maintenance fee for Hemodynamic risk severity based upon detection and quantification of cardiac dysrhythmia behavior using a pulse volume waveform (US 10,390,767) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
- 1 fee due May 3, 2027The maintenance fee for System and method for characterizing circulatory blood flow (US 9,173,579) comes due May 3, 2027. Unpaid by Nov 3, 2027, it lapses early.
- 1 fee due Jun 24, 2027The maintenance fee for System and method for characterizing circulatory blood flow (US 10,512,408) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
- 1 fee due Aug 25, 2027The maintenance fee for Methods and systems for predicting hypovolemic hypotensive conditions resulting from bradycardia behavior using a pulse volume waveform (US 10,568,583) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,678,057 | Device and System That Identifies Cardiovascular Insufficiency In force · High confidence | In force | High confidence | |
| US 9,002,440 | System and method for characterizing circulatory blood flow In force · From the USPTO record | In force | From the USPTO record | |
| US 9,173,579 | System and method for characterizing circulatory blood flow In force · From the USPTO record | In force | From the USPTO record | |
| US 10,512,408 | System and method for characterizing circulatory blood flow In force · From the USPTO record | In force | From the USPTO record | |
| US 10,390,767 | Hemodynamic risk severity based upon detection and quantification of cardiac dysrhythmia behavior using a pulse volume waveform In force · From the USPTO record | In force | From the USPTO record | |
| US 10,568,583 | Methods and systems for predicting hypovolemic hypotensive conditions resulting from bradycardia behavior using a pulse volume waveform In force · From the USPTO record | In force | From the USPTO record | |
| US 10,898,141 | System and method for characterizing respiratory stress In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 7: 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.